Data as of Sep 30
| +0.0314 / +12.63%|
The 1 analysts offering 12-month price forecasts for Rock Creek Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +614.29% increase from the last price of 0.28.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.